tm logo
ERAFYV
Live/Pending
PUBLICATION/ISSUE REVIEW COMPLETE

on 15 Feb 2024

Last Applicant/ Owned by

Rue de l'Institut 89

Rixensart

BE

B-1330

Serial Number

97251134 filed on 02th Feb 2022

Registration Number

N/A

Correspondent Address

Christopher M. Hanes

GSK

410 Blackwell Street

Legal Brand Protection

Durham, NC 27701

Filing Basis

No Filing Basis

Disclaimer

NO DATA

ERAFYV

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseaseRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines

Mark Details


Serial Number

No 97251134

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 84146593

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Feb 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12th Feb 2024APPROVED FOR PUB - PRINCIPAL REGISTER
22nd Jan 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22nd Jan 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
22nd Jan 2024TEAS/EMAIL CORRESPONDENCE ENTERED
19th Jan 2024ASSIGNED TO LIE
30th Aug 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
30th May 2023SUSPENSION INQUIRY WRITTEN
30th May 2023INQUIRY TO SUSPENSION E-MAILED
30th May 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED